Formed in 2019, bringing over 100+ years of collective experience in biopharmaceutical development.
Management Team
-
Terry Hermiston, Ph.D.
Founder & CEO
Site Head, Bayer HealthCare US Innovation Center
Vice President, Biologics Research US, Bayer HealthCare
> 25 years of industry experience
-
Derek Sim, Ph.D.
CSO
Principal Scientist, Bayer HealthCare, Hematology Research Department
Bayer FVII program lead
> 16 years of industry experience
-
Frank Booth
Chief Medical Officer
President, Booth Biomedical LLC
20+ Years as a practicing Surgical Intensivist, Clinical Educator and Clinical Trialist
-
Daekyeong Bae, Ph.D.
Senior Director, Operations
Deputy Director, Mirae Cell Bio
Venture Capitalist, Magellan Technology Investment
> 10 years of industry (biopharmaceutical and venture capital investment) experience
Board of Directors
-
Terry Hermiston, Ph.D.
Founder & CEO, Coagulant Therapeutics
Site Head, Bayer HealthCare US Innovation Center
Vice President, Biologics Research US, Bayer HealthCare
> 25 years of industry experience
-
Jinkyun Kim
Director, Korea Omega Investment Corp.
Investment Manager, The Korea Investment&Securities
Seoul National University, The department of Electronic Engineering
-
Mankyu Park
Principal, Deutsche Telekom Capital Partners
Head of Growth Equity / DTCP Korea
11+ year experience in financial investment spaces including investment banking, private equity, and venture capital
-
David Kirn, M.D.
CEO, 4D Molecular Therapeutics
Physician-scientist, medicines designer/developer, biotech entrepreneur & CEO with over 25 years of experience in the industry
Led programs from design concept through Phase 3 clinical trials
-
Robin Steele, J.D. , LL.M
Independent Board Member
Experienced Board member and former C-Suite executive with over 30 years of experience providing legal and strategic support to life science management teams and their boards of directors.
-
Wonchul Cho
Chief Portfolio Manager, Hana WM Center
Hana Bank
Emory University's Goizueta Business School